March 25, 2022
Felix Elected to AAN Section Leadership
Ana C. G. Felix, MBBCh, FAAN, has been elected as the American Academy of Neurology's 2022-2023 Vice Chair of the AB Baker Section on Neurological Education.
Category: Neurology
March 11, 2022
Statts Named Department of Neurology Interim Associate Chair for Administration
Robert Statts will begin his work in the interim role on March 17.
February 15, 2022
Phase 3 Study Results Show Positive Data in Treatment of Myasthenia Gravis with Zilucoplan
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was lead investigator in UCB's RAISE trial to evaluate zilucoplan as a treatment for generalized myasthenia gravis in adults.
February 3, 2022
Smith Named Vice Dean of the UNC Gillings School of Global Public Health
Robert Smith III, PhD, currently is associate chair for administration in the Department of Neurology. He will begin his new role on Feb. 28.
January 19, 2022
New Alzheimer’s Disease Research Forum to Launch in January
All trainees (fellows, postdocs, junior faculty, residents, research associates, etc.) interested in Alzheimer’s disease and related dementias (ADRD) are invited to attend the inaugural meeting of the ADRD IDEAS Forum to be held monthly by the Duke-UNC Alzheimer's Disease Research Center. The forum will be directed towards early-career investigators from Duke, UNC-CH, ECU, NCCU, and UNC-Pembroke.
January 3, 2022
FDA Approves New Drug to Treat Generalized Myasthenia Gravis
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
December 15, 2021
Diaz Receives AAN Clinical Research Training Scholarship
The American Academy of Neurology recently awarded neurologist Monica M. Diaz, MD, MS, a Clinical Research Training Scholarship in support of her research on the detection of neurodegeneration in older, cognitively-impaired people with HIV.
December 15, 2021
Reminder: Eshelman Institute Grant Funding Available
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics, and other therapeutic areas and services.
November 10, 2021
Funding Opportunities for UNC Alzheimer’s Disease Researchers
The Duke/UNC Alzheimer’s Disease Research Center (ADRC) is pleased to announce the release of three funding opportunities for researchers at Duke and UNC studying Alzheimer’s disease and related dementias.
October 26, 2021
UNC Health Earns National Recognition for Efforts to Improve Cerebrovascular Treatment
The American Heart Association presented UNC Health with multiple Achievement Awards for implementation of quality care at eight hospitals across the state.
October 26, 2021
DOD Funds $4.3-million Initiative to Improve Sleep, Clearance of the Brain
A multidisciplinary team of researchers will use new technology and imaging strategies to improve impaired waste clearance of the brain due to sleep disruption. The collaborative project is being co-led by Dawn Kernagis, PhD, at the UNC School of Medicine, and colleagues from the University of Washington, Oregon Health Science University, BEL Company, and Montana State University.
September 2, 2021
UNC Neurology Receives New Center of Excellence Designation
The Division of Neuromuscular Disorders has been designated as a GBS|CIDP Foundation International Center of Excellence for the diagnosis and treatment of Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and other inflammatory peripheral neuropathies.